AKT Inhibitor May Overcome Chemotherapy Resistance in 2 Breast Cancer Subtypes
A novel inhibitor that targets the AKT node in the PI3K pathway may offer a treatment option in cases of resistance to chemotherapy in 2 patient populations: triple-negative breast cancer or estrogen receptor
Read full article (External website)
Leave a Reply
Want to join the discussion?Feel free to contribute!